enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. FDA OKs New Self-Test for HPV, What to Know

   www.aol.com/lifestyle/fda-oks-self-test-hpv...

   The FDA has approved two new tests that allow women to perform a self-test to detect signs of HPV. These new tests may help cut out some pelvic exams at the gynecologist, that some people find ...

3. FDA approves HPV self-collecting test kit, expanding cervical ...

   www.aol.com/news/fda-approves-hpv-self...

   The FDA has given the green light to a self-collection solution to test for HPV, making it one of the easiest options available in the U.S. for identifying those at risk of cervical cancer.

4. Human papillomavirus infection - Wikipedia

   en.wikipedia.org/wiki/Human_papillomavirus_infection

   The aforementioned Qiagen/Digene kit was successfully used off-label to test the penis, scrotum, and anus [140] of men in long-term relationships with women who were positive for high-risk HPV. Of these men, 60% were found to carry the virus, primarily on the penis.

5. Gardasil - Wikipedia

   en.wikipedia.org/wiki/Gardasil

   In 2010, Gardasil was approved by the FDA for prevention of anal cancer and associated precancerous lesions due to HPV types 6, 11, 16, and 18 in people aged 9 through 26 years. [37] HPV infections, especially HPV 16, contribute to some head and neck cancer (HPV is found in an estimated 26–35% of head and neck squamous cell carcinoma). [38 ...

6. Cervical screening - Wikipedia

   en.wikipedia.org/wiki/Cervical_screening

   Human papillomavirus (HPV) infection is a cause of nearly all cases of cervical cancer. [6] Most women will successfully clear HPV infections within 18 months. Those that have a prolonged infection with a high-risk type (e.g. types 16, 18, 31, 45) are more likely to develop Cervical Intraepithelial Neoplasia, due to the effects that HPV has on ...

7. Merck to test single-dose regimen of HPV vaccine Gardasil 9 - AOL

   www.aol.com/news/merck-test-single-dose-regimen...

   The company said it plans to conduct two separate trials testing Gardasil 9 in men and women 16-26 years old to examine whether a single dose of the vaccine provides comparable long-term ...